Engineers Gate Manager’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Buy |
267,077
+180,357
| +208% | +$9.91M | 0.18% | 143 |
|
|
2025
Q1 | $6.13M | Buy |
86,720
+40,556
| +88% | +$2.87M | 0.1% | 268 |
|
|
2024
Q4 | $3.03M | Sell |
46,164
-64,533
| -58% | -$4.24M | 0.05% | 455 |
|
|
2024
Q3 | $7.78M | Buy |
110,697
+100,401
| +975% | +$7.06M | 0.15% | 168 |
|
|
2024
Q2 | $848K | Buy |
10,296
+5,258
| +104% | +$433K | 0.02% | 975 |
|
|
2024
Q1 | $440K | Buy |
+5,038
| New | +$440K | 0.01% | 1257 |
|
|
2023
Q3 | – | Sell |
-17,577
| Closed | -$1.52M | – | 1801 |
|
|
2023
Q2 | $1.52M | Buy |
17,577
+9,668
| +122% | +$838K | 0.06% | 469 |
|
|
2023
Q1 | $769K | Sell |
7,909
-9,971
| -56% | -$970K | 0.03% | 764 |
|
|
2022
Q4 | $1.85M | Sell |
17,880
-21,797
| -55% | -$2.26M | 0.11% | 211 |
|
|
2022
Q3 | $3.36M | Buy |
39,677
+26,262
| +196% | +$2.23M | 0.21% | 96 |
|
|
2022
Q2 | $1.11M | Buy |
+13,415
| New | +$1.11M | 0.04% | 631 |
|
|
2021
Q4 | – | Sell |
-3,541
| Closed | -$274K | – | 2022 |
|
|
2021
Q3 | $274K | Buy |
3,541
+941
| +36% | +$72.8K | 0.02% | 1244 |
|
|
2021
Q2 | $217K | Sell |
2,600
-13,275
| -84% | -$1.11M | 0.01% | 1360 |
|
|
2021
Q1 | $1.2M | Buy |
15,875
+7,852
| +98% | +$593K | 0.06% | 506 |
|
|
2020
Q4 | $704K | Buy |
+8,023
| New | +$704K | 0.03% | 763 |
|
|
2019
Q4 | – | Sell |
-38,705
| Closed | -$2.61M | – | 1619 |
|
|
2019
Q3 | $2.61M | Buy |
38,705
+9,305
| +32% | +$627K | 0.13% | 226 |
|
|
2019
Q2 | $2.52M | Buy |
+29,400
| New | +$2.52M | 0.14% | 232 |
|